Plastic Surgeon Dr. Dara Liotta’s clientele includes everyone from the stay-at-home mom to celebrities seeking to look camera ready. Here, she shares the biggest requests she gets from millennials, generation X and baby boomers, as well as her predictions for the next wave of trends in injectables and facial plastic surgery.

Baby Boomers (aged 53 to 71 years old) – This group has been requesting procedures focused on the eyes, specifically the upper and lower eyelids as well as eyebrows. They are looking for hidden incisions and minimally invasive procedures that can be done with minimal or no down time. “Baby boomers want to see and been seen naturally,” said Dr. Liotta.

Gen X (aged 41 to 52 years old) – Preventing or delaying the need for a facelift is the key characteristic of this group when it comes to plastic surgery. This generation is really concerned with aging in the neck and chest areas and they don’t want to look frozen because that’s what they saw on people when fillings were new. Botox for this generation is kept to a minimum. “I look at clients and think about what’s absolutely everything that I could Botox to be perfect in a picture, and then I take something away because I want the patient to still look natural. I do this for myself as well. On my face, I Botox my forehead, but I don’t do anything to my eyes and my crow’s feet because it’s what keeps me looking natural and not overdone,” she said.

Millinnials (aged 22 to 40 years old) – The younger generation wants to look like they have on a Snapchat filter at all times. They are interested in products that offer a real life Facetune app. Key areas of interest for this group include lip plumping, injection rhino, injection chin implants and Volbella under the eyes. To cater to this, Dr. Liotta created the Lit Lift, a full-face procedure of Botox and filler injections that can give the patient a semi-permeant makeup or strobing effect so they can look like they are under perfect lighting at all times.

What’s next for 2017?

“I really think that 2017 is going to be back to the face in terms of plastic surgery and less about the breast area,” she said, noting that many celebrities at the Oscars wore dresses with high necklines. “2017 is also going to be the year of many more designer fillers.”

A new filler, Juvederm Vollure, marketed as Volift, was recently FDA approved for the nasolabial folds and uses the same bi-cross technology that Allergan uses with Volume and Volbella to make it longer lasting. It can be used for people who want more cupid’s bow definition, to soften labial lines and fill in temple hollows.

Another filler expected to get approved later this year or in early 2018 is Volite, a Juvederm product that features the first injectable hyaluronic filler that is meant to improve skin quality and plump skin, while also helping to build collagen.

Finally, topical fat reduction may be a reality. Topokine Therapeutics is developing a cream called Topokine Latanoprost, which is meant to be applied under eyes at night to shrink fat cells. If it gets approved, it will be used on other areas as well, but undereye bags will be the first clinical application. Last year, Allergan bought the company for $85 million.